# A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.

> **NCT02635438** · PHASE3 · UNKNOWN · sponsor: **Thinq Pharma-CRO Pte. Ltd.** · enrollment: 360 (estimated)

## Conditions studied

- Oropharyngeal Candidiasis

## Interventions

- **DRUG:** Unique Pharmaceutical Laboratories, India
- **DRUG:** Roxane Laboratories Inc., USA

## Key facts

- **NCT ID:** NCT02635438
- **Lead sponsor:** Thinq Pharma-CRO Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-09
- **Final completion:** 2018-11
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2017-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02635438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02635438, "A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02635438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*